🎉Check out our largest CHIP GWAS to date of >1M participants, shedding light on how germline variation governs which somatic clones in blood expand with aging🧬
In parallel, we conducted CHIP PheWAS, linking CHIP to hematologic, cardiovascular, infectious, and other conditions🩸🫀🦠 medrxiv.org/content/10.1101/…@M_Mesbah_Uddin@AlexBickMDPhD@pnatarajanmd
A cholesterol AND #cardioonc curveball…& newly described IRAE?
#STAR future #bruinhearts chief @repettigiuliana Stumps the Profs w/ a ⁉️case of rapidly ⬆️ lipids after ICI myocarditis/hepatitis w/cholestatic injury ➡️ lipoprotein X!🤯 How 2 🔎?
🙏 to #ACCFIT chairs! #ACC26
Exciting research news!
DoM fellow, Dr. Michael Raddatz, and his team published groundbreaking research in @JClinicalInvest uncovering how CHIP mutations increase the risk of aortic valve disease. Their work could lead to new preventive treatments: uclahs.fyi/49JfFhi
@rheumrob,@AlexBickMDPhD, & I are excited to share that our work is now out in @jclinicalinvest! CHIP epi studies underestimate the association between CHIP & disease using WGS vs deep sequencing. Many thanks to the co-authors, participants, & reviewers! doi.org/10.1172/JCI198861
#ClonalHematopoiesis of indeterminate potential (CHIP) is common in older individuals, but its connection with aortic valve stenosis was unclear.
Here, @AlexBickMDPhD@StefanieDimmel1@AndreasZeiher@cpi_exstra reveal an association between TET2 mutations and aortic valve stenosis (n=886,378), showing #CHIP activates procalcific pathways in macrophages and promotes aortic valve stenosis: jci.org/articles/view/171634
The figure shows increased aortic valve calcification (OSM, green) and inflammation (S100A9, red) in a CHIP TET2-mutant mouse model; nuclei (DAPI, blue).
#ClonalHematopoiesis of indeterminate potential (CHIP) is common in older individuals, but its connection with aortic valve stenosis was unclear.
Here, @AlexBickMDPhD@StefanieDimmel1@AndreasZeiher@cpi_exstra reveal an association between TET2 mutations and aortic valve stenosis (n=886,378), showing #CHIP activates procalcific pathways in macrophages and promotes aortic valve stenosis: jci.org/articles/view/171634
The figure shows increased aortic valve calcification (OSM, green) and inflammation (S100A9, red) in a CHIP TET2-mutant mouse model; nuclei (DAPI, blue).
CHIP (TET2 and ASXL1 mutations) heightens risk of incident aortic stenosis through oncostatin M (OSM) signaling. OSM is in the family of IL-6 cytokines and signals through gp130 - makes me wonder what the effect of the IL-6R hypofunction variant/IL-6 blockade may be.
We still don't measure CHIP in the clinic (blood stem cell clones) which occur frequently with age and are a risk factor for cancer and heart disease. Here's how CHIP can lead to a calcified aortic valve. @jclinicalinvestjci.org/articles/view/171634